{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By JEFFREY GOLDFARB", "person": [{"firstname": "Jeffrey", "rank": 1, "lastname": "GOLDFARB", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "386", "keywords": [{"rank": "1", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Private Equity", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Nbty Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "The private equity firm bought the nutritional supplement maker using debt as leverage in 2010 and could potentially sell it now for $6 billion.", "pub_date": "2017-02-01T21:39:32+0000", "document_type": "article", "source": "The New York Times", "snippet": "The private equity firm bought the nutritional supplement maker using debt as leverage in 2010 and could potentially sell it now for $6 billion....", "multimedia": [], "web_url": "http://www.nytimes.com/2017/02/01/business/dealbook/healthy-payout-possible-for-carlyle-from-natures-bounty.html", "slideshow_credits": null, "blog": [], "_id": "5892559c7c459f2525d19eb6", "headline": {"main": "Healthy Payout Possible for Carlyle From Nature\u2019s Bounty", "content_kicker": "Breakingviews"}}